Makary Doubles Down on Push to ‘Modernize’ FDA, Eyes Speedier Reviews

By /

Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory landscape.

Scroll to Top